Electronic Approach to the Human Massage Therapist
Comparing an Electronic Approach to the Human Massage Therapist.
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
May 4, 2026
April 1, 2026
8 months
June 5, 2025
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients enrolled
Feasibility will be determined by the total number of patients screened in order to accrue the 40 needed to complete the study.
baseline to end of study (year 2)
Study Arms (2)
Indirect person massage therapy
EXPERIMENTALA massage therapist will program and direct an Artificial Intelligence Robotic Arm (EMMA) to deliver massage therapy. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch. This treatment will last approximately 20 minutes.
Direct person massage therapy
ACTIVE COMPARATORClinical massage treatment procedures are delivered by a clinically licensed massage therapist. This treatment will last approximately 20 minutes.
Interventions
Expert Manipulative Massage Automation (EMMA) is equipped with sensors to measure muscle stiffness and uses 3D vision technology to measure muscle stiffness and identify pressure points while delivering a massage to patients. Following that, the electronic massager will determine the best course of action for our patients based on the information stored by our Artificial Intelligence and EMMA's robotic arm will perform the massage. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch.
The direct person clinical massage treatment will be delivered by a clinical licensed massage therapist. The type of massage will follow the EMMA massage in that it will be a deep tissue massage (to mimic the Tuina massage) and generally will be for about 30 minutes to once again mimic the duration of massage therapy of the EMMA.
Eligibility Criteria
You may qualify if:
- be 18 years of age or older.
- report a primary pain point in the lower back.
- Pain intensity reported at baseline
- Women of childbearing potential who self-report not being pregnant and agree to employ an effective method of birth control (surgical sterilization or oral contraceptives, barrier method with spermicides, intrauterine device, etc.) during the study period
- be able to participate fully in all aspects of the study.
- have understood and signed study informed consent.
You may not qualify if:
- Pregnancy or breastfeeding
- Patients with the inability to stay in a prone position
- Patients with bleeding disorders
- Patients with allergies and/or local skin affectations
- have used pain medications or participated in a pain treatment within three days of study enrollment.
- have an implanted device (including a lap band) in the targeted area of massage therapy.
- have used an investigational drug within 30 days of study enrollment.
- have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
- have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2) active cancer, actively receiving treatment for cancer or within 1 year of cancer remission.
- surgical intervention for pain within 1 month prior to enrollment.
- active infection, wound or other external trauma to the areas to be treated with massage therapy.
- have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Mueller
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 5, 2025
First Posted
June 27, 2025
Study Start
January 30, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share